Nomura Asset Management CO LTD Halozyme Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $0 - $0	0 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$38.84 - $51.31 $0 - $0	0 New	0 $0
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $0 - $0	0 New	0 $0
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $0 - $0	0 New	0 $0
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $0 - $0	0 New	0 $0
Q1 2020 May 14, 2020	BUY	$13.9 - $21.83 $0 - $0	0 New	0 $0
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$15.2 - $17.69 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$14.75 - $17.26 $0 - $0	0 New	0 $0
Q1 2019 May 10, 2019	BUY	$13.94 - $17.58 $0 - $0	0 New	0 $0
Q1 2019 May 10, 2019	BUY	$13.94 - $17.58 $0 - $0	0 New	0 $0
Q4 2018 Feb 12, 2019	BUY	$13.33 - $18.66 $0 - $0	0 New	0 $0
Q3 2018 Nov 07, 2018	SELL	$16.68 - $18.41 $266,880 - $294,560	-16,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $268,000 - $332,800	16,000 New	16,000 $324,000
Q3 2017 Nov 13, 2017	BUY	$11.76 - $17.4 $0 - $0	0	0 $0

544

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.